These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 15494208

  • 1. CD38 cleavage in fMLP- and IL-8-induced chemotaxis is dependent on p38 MAP kinase but independent of p44/42 MAP kinase.
    Fujita T, Zawawi KH, Kurihara H, Van Dyke TE.
    Cell Signal; 2005 Feb; 17(2):167-75. PubMed ID: 15494208
    [Abstract] [Full Text] [Related]

  • 2. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or FMLP stimulation.
    Zu YL, Qi J, Gilchrist A, Fernandez GA, Vazquez-Abad D, Kreutzer DL, Huang CK, Sha'afi RI.
    J Immunol; 1998 Feb 15; 160(4):1982-9. PubMed ID: 9469462
    [Abstract] [Full Text] [Related]

  • 3. C-reactive protein inhibits chemotactic peptide-induced p38 mitogen-activated protein kinase activity and human neutrophil movement.
    Heuertz RM, Tricomi SM, Ezekiel UR, Webster RO.
    J Biol Chem; 1999 Jun 18; 274(25):17968-74. PubMed ID: 10364245
    [Abstract] [Full Text] [Related]

  • 4. The mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway is involved in formyl-methionyl-leucyl-phenylalanine-induced p47phox phosphorylation in human neutrophils.
    Dewas C, Fay M, Gougerot-Pocidalo MA, El-Benna J.
    J Immunol; 2000 Nov 01; 165(9):5238-44. PubMed ID: 11046057
    [Abstract] [Full Text] [Related]

  • 5. Membrane lipid microdomains differentially regulate intracellular signaling events in human neutrophils.
    Tuluc F, Meshki J, Kunapuli SP.
    Int Immunopharmacol; 2003 Dec 01; 3(13-14):1775-90. PubMed ID: 14636828
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activation and priming of neutrophil nicotinamide adenine dinucleotide phosphate oxidase and phospholipase A(2) are dissociated by inhibitors of the kinases p42(ERK2) and p38(SAPK) and by methyl arachidonyl fluorophosphonate, the dual inhibitor of cytosolic and calcium-independent phospholipase A(2).
    Mollapour E, Linch DC, Roberts PJ.
    Blood; 2001 Apr 15; 97(8):2469-77. PubMed ID: 11290612
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils.
    Coxon PY, Rane MJ, Uriarte S, Powell DW, Singh S, Butt W, Chen Q, McLeish KR.
    Cell Signal; 2003 Nov 15; 15(11):993-1001. PubMed ID: 14499342
    [Abstract] [Full Text] [Related]

  • 10. p38 Mitogen-activated protein kinase and extracellular signal-regulated kinase signaling pathways are not essential regulators of formyl peptide-stimulated p47(phox) activation in neutrophils.
    Tsai YR, Wang YJ, Lee MR, Hsu MF, Wang JP.
    Eur J Pharmacol; 2013 Feb 15; 701(1-3):96-105. PubMed ID: 23348708
    [Abstract] [Full Text] [Related]

  • 11. Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo.
    Partida-Sánchez S, Cockayne DA, Monard S, Jacobson EL, Oppenheimer N, Garvy B, Kusser K, Goodrich S, Howard M, Harmsen A, Randall TD, Lund FE.
    Nat Med; 2001 Nov 15; 7(11):1209-16. PubMed ID: 11689885
    [Abstract] [Full Text] [Related]

  • 12. Ketamine reduces inducible superoxide generation in human neutrophils in vitro by modulating the p38 mitogen-activated protein kinase (MAPK)-mediated pathway.
    Lu HW, He GN, Ma H, Wang JK.
    Clin Exp Immunol; 2010 Jun 15; 160(3):450-6. PubMed ID: 20345980
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of IL-8-mediated MAPK activation in human neutrophils by beta1 integrin ligands.
    Xythalis D, Frewin MB, Gudewicz PW.
    Inflammation; 2002 Apr 15; 26(2):83-8. PubMed ID: 11989791
    [Abstract] [Full Text] [Related]

  • 14. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP.
    Nick JA, Avdi NJ, Young SK, Knall C, Gerwins P, Johnson GL, Worthen GS.
    J Clin Invest; 1997 Mar 01; 99(5):975-86. PubMed ID: 9062356
    [Abstract] [Full Text] [Related]

  • 15. Endotoxin promotes neutrophil hierarchical chemotaxis via the p38-membrane receptor pathway.
    Wang X, Qin W, Zhang Y, Zhang H, Sun B.
    Oncotarget; 2016 Nov 08; 7(45):74247-74258. PubMed ID: 27655676
    [Abstract] [Full Text] [Related]

  • 16. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase.
    Tokuda H, Kozawa O, Uematsu T.
    J Bone Miner Res; 2000 Dec 08; 15(12):2371-9. PubMed ID: 11127202
    [Abstract] [Full Text] [Related]

  • 17. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases.
    Kampen GT, Stafford S, Adachi T, Jinquan T, Quan S, Grant JA, Skov PS, Poulsen LK, Alam R.
    Blood; 2000 Mar 15; 95(6):1911-7. PubMed ID: 10706854
    [Abstract] [Full Text] [Related]

  • 18. Actin reorganization and morphological changes in human neutrophils stimulated by TNF, GM-CSF, and G-CSF: the role of MAP kinases.
    Kutsuna H, Suzuki K, Kamata N, Kato T, Hato F, Mizuno K, Kobayashi H, Ishii M, Kitagawa S.
    Am J Physiol Cell Physiol; 2004 Jan 15; 286(1):C55-64. PubMed ID: 12954601
    [Abstract] [Full Text] [Related]

  • 19. Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of p38 mitogen-activated protein kinase activated by Src family kinases.
    Mócsai A, Jakus Z, Vántus T, Berton G, Lowell CA, Ligeti E.
    J Immunol; 2000 Apr 15; 164(8):4321-31. PubMed ID: 10754332
    [Abstract] [Full Text] [Related]

  • 20. Phosphorylation of cytosolic phospholipase A2 and the release of arachidonic acid in human neutrophils.
    Syrbu SI, Waterman WH, Molski TF, Nagarkatti D, Hajjar JJ, Sha'afi RI.
    J Immunol; 1999 Feb 15; 162(4):2334-40. PubMed ID: 9973512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.